Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spain discusses healthcare "overspend" on pharma:

This article was originally published in Clinica

Executive Summary

The Spanish government has spoken of the need to redirect funds earmarked for pharmaceuticals to "other priorities", in light of the continued growth in regional healthcare spending on drugs. A government report on the subject was at the centre of this week's discussions between the health ministry and the interregional council (Consejo Interterritorial) of the national healthcare system (SNS), in Bilbao. The report, according to El Pais, highlights a 23% rise in national spending on drugs to treat cardiovascular disease in 2003 - a major contributor to the 3% rise in drugs reimbursement during the last decade, to 93% of the total pharmaceutical spend.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel